<?xml version="1.0" encoding="UTF-8"?>
<p>Acute illness may have varying manifestations, and while the majority developed antibodies to the infection and immunity, 10–15 % go on to develop chronic disease and approximately 1 % will have fulminant failure. After exposure, the risk of developing chronic infection is indeed higher for newborns (90 %) than for infants and children &lt;5 years of age (25–30 %) or adolescents and adults (&lt;5 %) [
 <xref ref-type="bibr" rid="CR99">99</xref>]. To reduce mother-to-child transmission, the World Health Organization recommends the administration of both the vaccine and hepatitis B immunoglobulins (HBIG) to newborns of HBsAg-positive mothers within 24 h from birth (90–98 % protection rate) [
 <xref ref-type="bibr" rid="CR100">100</xref>, 
 <xref ref-type="bibr" rid="CR101">101</xref>]. HBsAg and HBV DNA can be detected in breast milk of chronic carriers, but no increased risk of transmission to a breast-fed infant has been shown and breastfeeding is currently recommended after proper infant immunization [
 <xref ref-type="bibr" rid="CR102">102</xref>].
</p>
